LZTS2 Negatively Regulates Centrosomal CEP135 Levels and Microtubule Nucleation

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• The microtubule cytoskeleton is crucial for cellular functions.
• Centrosomes act as the primary microtubule organizing centers (MTOCs) in vertebrate proliferating cells.
• Dysregulation of centrosomes is linked to genomic instability and cancer, with LZTS2 identified as a tumor suppressor involved in microtubule severing.

Purpose of the Study:

• To investigate the function of LZTS2 at the centrosome.
• To determine LZTS2's role in regulating centrosome structure, microtubule organization, and ciliation.

Main Methods:

• Fluorescence and electron microscopy were employed to assess centrosome structure and ciliation.
• LZTS2 and CEP135 knockdown experiments were performed.
• Microtubule nucleation assays were conducted.

Main Results:

• LZTS2 knockdown did not impact centriole biogenesis, structure, or ciliation.
• Depletion of LZTS2 led to increased microtubule nucleation at the centrosome.
• LZTS2 was found to negatively regulate centrosomal levels of CEP135.
• LZTS2 depletion partially rescued impaired microtubule nucleation caused by CEP135 knockdown.

Conclusions:

• LZTS2 functions as a novel negative regulator of CEP135 and centrosomal microtubule nucleation.
• This regulatory role provides a potential mechanistic link to LZTS2's tumor suppressor activity.
• Understanding LZTS2's function at the centrosome may offer new avenues for cancer therapy.